rs3734050

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001447.3(FAT2):​c.10507-52G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0932 in 1,410,692 control chromosomes in the GnomAD database, including 6,606 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.11 ( 970 hom., cov: 33)
Exomes 𝑓: 0.091 ( 5636 hom. )

Consequence

FAT2
NM_001447.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.136

Publications

15 publications found
Variant links:
Genes affected
FAT2 (HGNC:3596): (FAT atypical cadherin 2) This gene is the second identified human homolog of the Drosophila fat gene, which encodes a tumor suppressor essential for controlling cell proliferation during Drosophila development. The gene product is a member of the cadherin superfamily, a group of integral membrane proteins characterized by the presence of cadherin-type repeats. In addition to containing 34 tandem cadherin-type repeats, the gene product has two epidermal growth factor (EGF)-like repeats and one laminin G domain. This protein most likely functions as a cell adhesion molecule, controlling cell proliferation and playing an important role in cerebellum development. [provided by RefSeq, Jul 2008]
SLC36A1 (HGNC:18761): (solute carrier family 36 member 1) This gene encodes a member of the eukaryote-specific amino acid/auxin permease (AAAP) 1 transporter family. The encoded protein functions as a proton-dependent, small amino acid transporter. This gene is clustered with related family members on chromosome 5q33.1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
MIR6499 (HGNC:49962): (microRNA 6499) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 5-151522138-C-T is Benign according to our data. Variant chr5-151522138-C-T is described in ClinVar as Benign. ClinVar VariationId is 1277460.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001447.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAT2
NM_001447.3
MANE Select
c.10507-52G>A
intron
N/ANP_001438.1Q9NYQ8
MIR6499
NR_106752.1
n.11G>A
non_coding_transcript_exon
Exon 1 of 1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAT2
ENST00000261800.6
TSL:1 MANE Select
c.10507-52G>A
intron
N/AENSP00000261800.5Q9NYQ8
FAT2
ENST00000520200.5
TSL:1
c.1081-52G>A
intron
N/AENSP00000429678.1H0YBK2
MIR6499
ENST00000621322.1
TSL:6
n.11G>A
non_coding_transcript_exon
Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16324
AN:
152064
Hom.:
969
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.0815
Gnomad AMR
AF:
0.0830
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.0385
Gnomad SAS
AF:
0.0551
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0907
Gnomad OTH
AF:
0.0994
GnomAD2 exomes
AF:
0.0908
AC:
10434
AN:
114970
AF XY:
0.0885
show subpopulations
Gnomad AFR exome
AF:
0.167
Gnomad AMR exome
AF:
0.0749
Gnomad ASJ exome
AF:
0.131
Gnomad EAS exome
AF:
0.0328
Gnomad FIN exome
AF:
0.107
Gnomad NFE exome
AF:
0.0998
Gnomad OTH exome
AF:
0.0827
GnomAD4 exome
AF:
0.0915
AC:
115135
AN:
1258510
Hom.:
5636
Cov.:
19
AF XY:
0.0900
AC XY:
55304
AN XY:
614748
show subpopulations
African (AFR)
AF:
0.166
AC:
4809
AN:
29054
American (AMR)
AF:
0.0717
AC:
2054
AN:
28648
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
2109
AN:
19768
East Asian (EAS)
AF:
0.0797
AC:
2817
AN:
35332
South Asian (SAS)
AF:
0.0503
AC:
3397
AN:
67520
European-Finnish (FIN)
AF:
0.100
AC:
4704
AN:
47002
Middle Eastern (MID)
AF:
0.0590
AC:
212
AN:
3596
European-Non Finnish (NFE)
AF:
0.0925
AC:
90162
AN:
975238
Other (OTH)
AF:
0.0930
AC:
4871
AN:
52352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
4969
9938
14906
19875
24844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3446
6892
10338
13784
17230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16354
AN:
152182
Hom.:
970
Cov.:
33
AF XY:
0.106
AC XY:
7897
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.161
AC:
6689
AN:
41504
American (AMR)
AF:
0.0831
AC:
1271
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
378
AN:
3470
East Asian (EAS)
AF:
0.0384
AC:
199
AN:
5180
South Asian (SAS)
AF:
0.0558
AC:
269
AN:
4824
European-Finnish (FIN)
AF:
0.102
AC:
1077
AN:
10578
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0907
AC:
6171
AN:
68010
Other (OTH)
AF:
0.0993
AC:
210
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
725
1451
2176
2902
3627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0909
Hom.:
931
Bravo
AF:
0.110
Asia WGS
AF:
0.0590
AC:
205
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.2
DANN
Benign
0.61
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3734050; hg19: chr5-150901699; API